Worldwide Sports News

As Clayton Kershaw completed his pregame routine the other day and walked off the field at Citizens Bank Park, I asked him about his postseason debut. That was 17 years and 39 playoff appearances ago, and yet Kershaw remembered it so well that he got his answer out before I got all of my question out.

“I was in the ‘pen,” Kershaw said. “Here.”

The pitching staff of the 2008 Dodgers featured two Hall of Famers: Kershaw, in his first year, and Greg Maddux, in his last year.

When the Dodgers faced the Philadelphia Phillies in the National League Championship Series, Derek Lowe, Hiroki Kuroda and Chad Billingsley made the cut as starters. Kershaw and Maddux did not.

Read more:Hernández: Dodgers save Shohei Ohtani, not the other way around, in monumental Game 1 NLDS win

“He and I were both kind of the long guys down there,” Kershaw said. “It’s crazy, kind of the similarities.

“Where I am now is kind of where he was. It’s pretty cool.”

For just about every player, baseball tells you when your career is over. Maddux, for all his accolades, was no exception.

In each of his last five seasons, his earned-run average was above 4.00, even as he pitched at least 194 innings in each of them. In his last stint with the Dodgers — seven starts at the end of the 2008 season — his ERA was 5.09.

Maddux knew that postseason would be the end for him. He just didn’t tell anyone.

In his last outing — in the game in which the Phillies eliminated the Dodgers — Maddux was one of six Dodgers relievers. He worked the fourth and fifth innings, left the mound with the Dodgers down by five runs, and quietly asked the plate umpire for a baseball on his way out.

“I’ve got the ball in my room somewhere,” Maddux told The Times in 2014. “It kind of stunk that we lost. But I knew it was the last time I was going to put on a uniform. I was privileged to wear it for as long as I did.”

Kershaw is the rare player that has told baseball when his career is over. He announced his retirement last month, effective at the end of the season, even as he is still mighty effective.

His .846 winning percentage would have led the major leagues, had he thrown another 50 innings. He still threw more innings than anyone on the Dodgers except Yoshinobu Yamamoto, and his 3.36 ERA was his third-worst in a full season. In his final start, he shut out the American League West champion Seattle Mariners into the sixth inning.

In a normal year for the Dodgers, Kershaw would be starting in the playoffs, because a normal year for the Dodgers means scooping up a bunch of talented pitchers with histories of injury and questions of durability, then crossing their fingers and hoping a few are healthy and effective come playoff time.

Last October, the Dodgers ran short: Yamamoto, Jack Flaherty, Walker Buehler and four bullpen games. This October, almost miraculously, the Dodgers have five available starters with an ERA better than Kershaw: Yamamoto, Blake Snell, Shohei Ohtani, Tyler Glasnow and Emmet Sheehan.

Andrew Friedman, the Dodgers’ president of baseball operations, admitted to some trepidation at telling a Hall of Famer that he would be bound for the postseason bullpen.

“But, to Kersh’s credit, he cuts off that timidness in a way by saying, ‘Hey, I'm here to win, whatever it takes,’” Friedman said. “He’s loved watching these guys compete. Obviously he’s done really well this year as well.

“Usually, when a guy’s on his way out, it's like, ‘OK, it's time.’ You can kind of see it. The performance really backs up. That's not the case with Kersh. He was a big part of the success we had this year. But to his credit, he cut it off really early and just said, ‘Hey, I just want to be part of this and help this team win, whatever way I can.’ And so he helped make that conversation way easier.”

If Kershaw works four innings this October, he’ll pass Maddux for sixth place on the all-time list of postseason innings pitched. If he pitches 5⅔ innings, he’ll become the fifth pitcher to throw 200 postseason innings, joining Andy Pettitte, Justin Verlander, Tom Glavine and John Smoltz.

In the future, fans will flip over Kershaw’s baseball card — or, more likely, look up his Baseball Reference page — and learn that the greatest starter of his generation finished his career in relief.

A curiosity, at the least, I suggested. Kershaw shrugged.

“The postseason is just its own separate thing,” he said. “You just do whatever you can. Where our team is at with our starters, it makes sense.

“I guess it's weird, but it’s part of it.”

In his postseason debut here in 2008, Kershaw retired the first five batters, not bad when four of them were named Jimmy Rollins, Shane Victorino, Chase Utley and Ryan Howard. In his finale in that 2008 NLCS, Maddux got the last man he faced to ground out: Cole Hamels — in the old days, when pitchers used to bat.

Kershaw might not throw another pitch; the Dodgers have made no commitment to use him in this round, or to keep him on the roster if they advance beyond then.

Read more:Tyler Glasnow and Roki Sasaki showcase Dodgers' bullpen blueprint for playoffs

On Sunday, I asked Dodgers manager Dave Roberts whether Kershaw was here only in case a starter exited in a hurry or a game went into extra innings.

“I trust him,” Roberts said. “I think there’s other opportunities he might have to pitch. But I also do feel that there’s other guys, whether it’s lanes or spots, that I feel we're more comfortable with.

“It’s not a slight on Clayton, but I do think that there's various roles — up, down, early, late — that I could use him.”

The Dodgers are using starters wherever they can: starting, relieving, closing. Given the anxiety-inducing state of the Dodgers bullpen, the notion that they might not be able to find a spot to use Kershaw leaves only one question: Seriously?

Sign up for more Dodgers news with Dodgers Dugout. Delivered at the start of each series.

This story originally appeared in Los Angeles Times.

‘This window is upon us': Red Sox discuss offseason priorities after early exit originally appeared on NBC Sports Boston

The Boston Red Sox held their annual end-of-season press conference on Monday morning, discussing some of their key off-season priorities after making an early playoff exit.

Those speaking included President and CEO Sam Kennedy, Chief Baseball Officer Craig Breslow and manager Alex Cora.

“I want to express huge thanks to our fans for giving us what was a great step in the right direction in 2025,” Kennedy said. “Our fans proved once again why they’re the best in baseball. You guys packed the house night in and night out… We never take that support for granted, we appreciate you guys and we’re excited for 2026. While we fell short of our ultimate goal this year, it was definitely a step in the right direction.”

Breslow echoed those comments, saying Fenway was “electric” this season.

“We’re sitting here in the first week of October, which means we didn’t accomplish what we set out to accomplish — a deep postseason run,” he added. “We fell short of that and I don’t think there’s any running from it or hiding from it. That shouldn’t diminish what the players did, what the staff did… There are a number of things we can point to as reasons for optimism.”

Cora reflected on what he said was one of the most fun groups of players he’s ever managed.

“I’m disappointed at the results — that’s not what I wanted — but as far as the overall season for me, I had a blast,” he said. “We really enjoyed it. I think this place made it special. To come here every single day and win here and to have the energy we had throughout the season, that was special.”

The Red Sox finished the season as the No. 5 seed in the American League, landing the second Wild Card spot. But they lost to the archrival New York Yankees 2-1 in the Wild Card series.

Still, the season was mostly viewed as a success, especially given the development of young players like Roman Anthony and Marcelo Mayer and the fact that the team hadn’t qualified for the playoffs since 2021.

Now, the speculation turns toward what the team will do in the offseason, including whether they will re-sign third baseman Alex Bregman, trade one of their four outfielders or sign a top-tier free agent starter to bolster their rotation.

Breslow said he was particularly impressed with the emergence of the organization’s pitching development pipeline this season, but said that won’t stop him from pursuing another front-line starter to augment a rotation led by ace Garrett Crochet.

“I think there are a few things we can point to — most significant is to remind ourselves that there’s no guarantee that we just pick up where we left off at the end of 2025, expecting everyone to take a step forward. That could allow us to be complacent… We’ve talked a lot about how this window is upon us.”

Breslow said one area to look at is improving the team’s defense, and another is hitting with runners in scoring position.

“But right now, we’ll kind of zoom out a little bit and take stock of where we are,” he said. “We’ll be open to all possible pathways to improving the team.”

Breslow was asked about the future of several key players — including Bregman, Trevor Story, Jarren Duran, Tristan Casas and Lucas Giolito — all of whom could move on or be traded this offseason. But he said it is too soon to discuss specifics.

As for whether the team has enough pitching, Breslow said there is always a need for more major league arms, as demonstrated this postseason.

“No one will sit in this seat and say there is enough pitching in the organization,” he said. “I think we saw that in the second half. We can list out pitchers that were on the IL, and it just means that depth is so critically important. When we talk about pursuing opportunities to improve the team, bringing in pitching is certainly one of them.”

More than four years after the family of deceased Angels pitcher Tyler Skaggs filed a wrongful death suit against the Angels, jury selection will begin Monday in Orange County Superior Court.

Skaggs' widow Carli Skaggs and parents Debra Hetman and Darrell Skaggs stated in a court filing that they seek at least $210 million in lost earnings and damages. A lawyer for the Angels said in a pretrial hearing that the plaintiffs now seek a judgment of $1 billion, although the lead attorney representing the family said the number is an exaggeration.

The trial is expected to last several weeks. Pretrial discovery included more than 50 depositions and the witness list contains nearly 80 names.

Lawyers for the Skaggs family aim to establish that the Angels were responsible for the death of the 27-year-old left-handed pitcher on July 1, 2019, after he snorted crushed pills that contained fentanyl in a hotel room during a team road trip in Texas.

An autopsy concluded Skaggs accidentally died of asphyxia after aspirating his own vomit while under the influence of fentanyl, oxycodone and alcohol.

Angels communications director Eric Kay provided Skaggs with counterfeit oxycodone pills that turned out to be laced with fentanyl and is serving 22 years in federal prison for his role in the death. Skaggs' lawyers will try to prove that other Angels employees knew Kay was providing opioids to Skaggs.

Read more:Tyler Skaggs' family sues Angels over pitcher's death

“The Angels owed Tyler Skaggs a duty to provide a safe place to work and play baseball,” the lawsuit said. “The Angels breached their duty when they allowed Kay, a drug addict, complete access to Tyler. The Angels also breached their duty when they allowed Kay to provide Tyler with dangerous illegal drugs. The Angels should have known Kay was dealing drugs to players. Tyler died as a result of the Angels’ breach of their duties.”

The Skaggs family planned to call numerous current and former Angels players as witnesses, including future Hall of Famers Mike Trout and Albert Pujols as well as pitcher Andrew Heaney — Skaggs' best friend on the team — in an attempt to show that Skaggs was a fully functioning major league pitcher and not an addict.

Pretrial filings and hearings indicated that the Angels were attempting to show that Skaggs was a longtime drug user who acquired pills from sources other than Kay. Skaggs' mother, Debbie Hetman, testified during Kay's 2022 criminal trial that her son admitted he had an “issue” with oxycodone as far back as 2013.

Hetman said her son quit "cold turkey" but she testified the addiction remained enough of a concern that Skaggs wasn’t prescribed opioids after undergoing Tommy John surgery in August 2014.

Judge H. Shaina Colover dashed a key Angels defense strategy when she ruled that Kay’s criminal conviction could not be disputed during the civil trial. Angels attorney Todd Theodora contended that new evidence indicated Skaggs died of a “cardiac arrhythmia, second to the fact that Tyler had 10 to 15 drinks in him, coupled with the oxycodone, for which Angels baseball is not responsible.”

Read more:Eric Kay found guilty of supplying drugs that led to death of Angels' Tyler Skaggs

Theodora said that if the Angels could prove Kay was not guilty beyond a reasonable doubt, neither Kay nor the team would be culpable in Skaggs’ death. Colover, however, ruled that Kay's "conviction, based on applicable law and facts, was final." Kay's appeal was denied in federal court in November 2023.

Pretrial depositions of Angels players and support personnel provided a rare glimpse into the rowdy, often profane culture of a major league clubhouse.

Angels clubhouse attendants testified that Kay participated in stunts such as purposely taking an 85-mph fastball off his knee in the batting cage, having a pitcher throw a football at his face from short range, eating a bug and eating pimples off the back of Trout.

Tim Mead, the Angels longtime vice president of communication and Kay's supervisor, acknowledged as much in his deposition, saying, "If you try to describe a clubhouse or a locker room in professional sports, or even college, and probably even the military in terms, and try to equate it to how we see — how this law firm is run or a corporation is run, you know, unfortunately, there's not lot of comparison.... There's a lot of fun, there's a lot of release."

And a lot of painkillers. Former Angels players Matt Harvey, C.J. Cron, Mike Morin and Cam Bedrosian testified at Kay's trial that he distributed blue 30 milligram oxycodone pills to them at Angel Stadium. Skaggs, testimony revealed, was a particularly frequent customer.

Read more:Tyler Skaggs' death revisited as MLB partners with White House to reduce opioid overdoses

Testimony established that Kay was also a longtime user of oxycodone and that the Angels knew it. In a filing, the Skaggs family showed evidence that Angels team physician Craig Milhouse prescribed Kay Hydrocodone 15 times from 2009 to 2012. The Skaggs family also plans to call Trout, who according to the deposition of former Angels clubhouse attendant Kris Constanti, offered to pay for Kay’s drug rehabilitation in 2018.

Skaggs was a top prospect coming out of Santa Monica High in 2009, and the Angels made him their first-round draft pick. He was traded to the Arizona Diamondbacks a year later and made his major league debut with them in 2012.

Traded back to the Angels in 2014, Skaggs made the starting rotation, where he remained when not battling injuries until his death. His numbers were rather ordinary, a 28-38 win-loss record with a 4.41 earned-run average in 96 career starts, but his lawyers pointed to his youth and the escalating salaries given to starting pitchers in asking for a jury award of at least $210 million and as much as $785 million.

Skaggs earned $9.2 million — including $3.7 million in 2019 — and would have become a free agent after the 2020 season. Effective starting pitchers at a similar age and comparable performance can command multi-year contracts of $100 million or more.

Skaggs' death prompted MLB to begin testing for opioids and cocaine in 2020, but only players who do not cooperate with their treatment plans are subject to discipline. Marijuana was removed from the list of drugs of abuse and is treated the same as alcohol.

MLB emergency medical procedures now require that naloxone be stored in clubhouses, weight rooms, dugouts and umpire dressing rooms at all ballparks. Naloxone, also known by the brand name Narcan, is an antidote for opioid poisoning.

Get the best, most interesting and strangest stories of the day from the L.A. sports scene and beyond from our newsletter The Sports Report.

This story originally appeared in Los Angeles Times.